MiraDx Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
MiraDx is a biotechnology research company focused on discovering and applying microRNA-based genetic biomarkers to inform personalized cancer treatment. The biomarkers help guide decisions across radiation, chemotherapy, and emerging immunotherapies, and they address treatment-related toxicity in ways not previously demonstrated by other biomarker sets. Founded by Joanne Weidhaas, M.D., Ph.D., and Frank Slack, Ph.D., the company operates as a small to mid-sized team based in Los Angeles, California. The company operates within the biotechnology research sector and pursues worldwide collaborations with academic and industry partners to advance these biomarkers for personalized cancer therapy. It maintains a sister nonprofit, MiraKind, reflecting a broader ecosystem around its work.